About Ultrast Medtech Pte Ltd
Ultrast MedTech, based on the two major technology platforms ：ultrasound and robotics, provide overall solutions from tumor diagnosis, image fusion, surgical navigation and local treatment.
The company's core management team includes scientists from NTU and NUS; technical talents from well-known medical companies; a group of excellent software professionals with interdisciplinary backgrounds in artificial intelligence, biomedical science, medical imaging, mechanical electronics, and industrial design. hardware engineer.
In foreign countries, the company established a research and development center in Singapore in the early days (2016), and actively carried out multiple research and development with Nanyang Technological University (NTU), National University of Singapore (NUS), Singapore Agency for Science, Technology and Research (A*STAR), Singapore General Hospital and other institutions. We have successfully developed a series of projects with medical practical value. In China, the company has carried out extensive and in-depth scientific research cooperation with Zhujiang Hospital Affiliated to Southern Medical University and ShenZhen University.
Singapore Agency for Science, Technology and Research
Ultrast Medtech will continue to promote scientific research and development, technological innovation and industrialization of scientific research results, strive to realize the modernization and popularization of medical technology, and benefit mankind together with medical workers.
Excellent systematic R&D and innovation capabilities; advanced quality management and intelligent manufacturing system, nationwide deep coverage, professional service sales system; all-round, full-time, whole-process after-sales service system; stable and professional management team.
The company will continue to develop products such as urology ultrasound, anesthesia ultrasound, colorectal ultrasound, intelligent medical surgical robot, new type of automatic tracking and positioning in vitro lithotripter, and new shock wave cardiovascular treatment system.